Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G N Beatch

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Pharmacology|January 21, 1992
Mexiletine's antifibrillatory actions are limited by the occurrence of convulsions in conscious animalsL N Igwemezie, G N Beatch, K M McErlane, et al.
The Canadian Journal of Cardiology|March 18, 1999
Dofetilide enhances shock-induced extension of refractoriness and lowers defibrillation thresholdD R Davis, G N Beatch, D R Dickenson, et al.
British Journal of Pharmacology|January 1, 1991
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blockerG N Beatch, S Abraham, B A MacLeod, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditionsS L Yong, R Xu, J G McLarnon, et al.
Scientific Reports|February 5, 2022
Spontaneous and TMS-related EEG changes as new biomarkers to measure anti-epileptic drug effectsAndrea Biondi, L Rocchi, V Santoro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 11, 2018
Pharmacological and toxicological activity of RSD921, a novel sodium channel blockerM J A Walker, E S Hayes, D A Saint, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Pharmacology|January 21, 1992
Mexiletine's antifibrillatory actions are limited by the occurrence of convulsions in conscious animalsL N Igwemezie, G N Beatch, K M McErlane, et al.
The Canadian Journal of Cardiology|March 18, 1999
Dofetilide enhances shock-induced extension of refractoriness and lowers defibrillation thresholdD R Davis, G N Beatch, D R Dickenson, et al.
British Journal of Pharmacology|January 1, 1991
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blockerG N Beatch, S Abraham, B A MacLeod, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditionsS L Yong, R Xu, J G McLarnon, et al.
Scientific Reports|February 5, 2022
Spontaneous and TMS-related EEG changes as new biomarkers to measure anti-epileptic drug effectsAndrea Biondi, L Rocchi, V Santoro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 11, 2018
Pharmacological and toxicological activity of RSD921, a novel sodium channel blockerM J A Walker, E S Hayes, D A Saint, et al.
Pageof 2